SG11201705495XA - Identification of functional cell states - Google Patents
Identification of functional cell statesInfo
- Publication number
- SG11201705495XA SG11201705495XA SG11201705495XA SG11201705495XA SG11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA SG 11201705495X A SG11201705495X A SG 11201705495XA
- Authority
- SG
- Singapore
- Prior art keywords
- identification
- functional cell
- cell states
- states
- functional
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B99/00—Subject matter not provided for in other groups of this subclass
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5026—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on cell morphology
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/40—Searching chemical structures or physicochemical data
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C99/00—Subject matter not provided for in other groups of this subclass
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Theoretical Computer Science (AREA)
- Bioinformatics & Computational Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Computing Systems (AREA)
- Physiology (AREA)
- Evolutionary Biology (AREA)
- Medical Informatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461927247P | 2014-01-14 | 2014-01-14 | |
| PCT/US2015/011441 WO2015109003A1 (fr) | 2014-01-14 | 2015-01-14 | Identification d'états de cellules fonctionnelles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201705495XA true SG11201705495XA (en) | 2017-08-30 |
Family
ID=52440877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201705495XA SG11201705495XA (en) | 2014-01-14 | 2015-01-14 | Identification of functional cell states |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US11137388B2 (fr) |
| EP (1) | EP3094974B1 (fr) |
| JP (1) | JP6606100B2 (fr) |
| KR (1) | KR102413041B1 (fr) |
| AU (2) | AU2015206520B2 (fr) |
| CA (1) | CA2972960C (fr) |
| DK (1) | DK3094974T3 (fr) |
| ES (1) | ES2728119T3 (fr) |
| HK (1) | HK1231553A1 (fr) |
| IL (1) | IL246734B (fr) |
| SG (1) | SG11201705495XA (fr) |
| WO (1) | WO2015109003A1 (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3094974T3 (da) * | 2014-01-14 | 2019-05-27 | Asedasciences Ag | Identifikation af funktionelle cellers tilstande |
| CN107250716B (zh) | 2015-02-24 | 2020-07-24 | 国立大学法人东京大学 | 动态高速高灵敏度成像装置及成像方法 |
| EP3372985A4 (fr) * | 2015-10-28 | 2019-09-18 | The University Of Tokyo | Dispositif d'analyse |
| US10824693B2 (en) * | 2015-12-10 | 2020-11-03 | Reservoir Labs, Inc. | Systems and methods for selective expansive recursive tensor analysis |
| US11205103B2 (en) | 2016-12-09 | 2021-12-21 | The Research Foundation for the State University | Semisupervised autoencoder for sentiment analysis |
| US11573182B2 (en) | 2017-05-25 | 2023-02-07 | FlowJo, LLC | Visualization, comparative analysis, and automated difference detection for large multi-parameter data sets |
| EP3807005B1 (fr) | 2018-06-13 | 2023-10-25 | ThinkCyte K.K. | Méthodes et systèmes de cytométrie |
| US11972858B2 (en) | 2019-05-14 | 2024-04-30 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | System and method for characterizing cellular phenotypic diversity from multi-parameter cellular, and sub-cellular imaging data |
| WO2022026532A1 (fr) * | 2020-07-30 | 2022-02-03 | Allen Institute | Systèmes, dispositifs et procédés de criblage de composés au moyen d'un marquage prédictif |
| WO2023009513A1 (fr) | 2021-07-26 | 2023-02-02 | Asedasciences Ag | Procédés améliorés d'identification d'états de cellules fonctionnelles |
| WO2023056481A1 (fr) * | 2021-10-01 | 2023-04-06 | CAP Diagnostics, LLC, dba Pathnostics | Méthodes et systèmes automatisés d'identification rapide de particules cibles |
| US12105081B2 (en) | 2021-10-20 | 2024-10-01 | Travera, Inc. | Treatment response assessment using normalized single cell measurements |
| WO2024158752A1 (fr) | 2023-01-23 | 2024-08-02 | Asedascience, Ag | Systèmes d'interaction homme-machine améliorés |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5544650A (en) | 1988-04-08 | 1996-08-13 | Neuromedical Systems, Inc. | Automated specimen classification system and method |
| AU6024294A (en) | 1993-01-08 | 1994-08-15 | Coulter Corporation | Method of using preserved control cells in the calibration of fluorescent and light scatter measurements |
| CA2196496A1 (fr) | 1997-01-31 | 1998-07-31 | Stephen William Watson Michnick | Epreuve de complementation de fragments de proteines pour la detection d'interactions entre proteines |
| US20050221280A1 (en) | 1998-02-02 | 2005-10-06 | Odyssey Thera, Inc. | Protein-protein interactions for pharmacological profiling |
| US7166424B2 (en) | 1998-02-02 | 2007-01-23 | Odyssey Thera Inc. | Fragments of fluorescent proteins for protein fragment complementation assays |
| US6801859B1 (en) | 1998-12-23 | 2004-10-05 | Rosetta Inpharmatics Llc | Methods of characterizing drug activities using consensus profiles |
| US6998249B1 (en) | 1999-09-27 | 2006-02-14 | Pharmacia & Upjohn Company | Toxicity screening method |
| AU2001240074B2 (en) | 2000-03-06 | 2006-02-23 | Bioseek, Inc. | Function homology screening |
| EP1290428A1 (fr) | 2000-06-02 | 2003-03-12 | Medicometrics APS | Methode et systeme de classification d'un echantillon biologique |
| US7146349B2 (en) * | 2000-11-06 | 2006-12-05 | International Business Machines Corporation | Network for describing multimedia information |
| US20070135997A1 (en) * | 2003-04-23 | 2007-06-14 | Evangelos Hytopoulos | Methods for analysis of biological dataset profiles |
| EP1620722A4 (fr) | 2003-04-23 | 2008-01-30 | Bioseek Inc | Procedes de caracterisation de voies de signalisation et composes interagissant avec ceux-ci |
| WO2008134593A1 (fr) * | 2007-04-25 | 2008-11-06 | President And Fellows Of Harvard College | Circuits moléculaires |
| US20130226469A1 (en) | 2008-04-01 | 2013-08-29 | Purdue Research Foundation | Gate-free flow cytometry data analysis |
| US8831889B2 (en) | 2008-04-01 | 2014-09-09 | Purdue Research Foundation | Quantification of differences between measured values and statistical validation based on the differences |
| DK3094974T3 (da) * | 2014-01-14 | 2019-05-27 | Asedasciences Ag | Identifikation af funktionelle cellers tilstande |
-
2015
- 2015-01-14 DK DK15702063.7T patent/DK3094974T3/da active
- 2015-01-14 CA CA2972960A patent/CA2972960C/fr active Active
- 2015-01-14 SG SG11201705495XA patent/SG11201705495XA/en unknown
- 2015-01-14 WO PCT/US2015/011441 patent/WO2015109003A1/fr active Application Filing
- 2015-01-14 US US15/111,339 patent/US11137388B2/en active Active
- 2015-01-14 US US14/596,957 patent/US20150198584A1/en not_active Abandoned
- 2015-01-14 EP EP15702063.7A patent/EP3094974B1/fr active Active
- 2015-01-14 KR KR1020167022058A patent/KR102413041B1/ko active IP Right Grant
- 2015-01-14 ES ES15702063T patent/ES2728119T3/es active Active
- 2015-01-14 JP JP2016563912A patent/JP6606100B2/ja active Active
- 2015-01-14 AU AU2015206520A patent/AU2015206520B2/en active Active
-
2016
- 2016-07-12 IL IL246734A patent/IL246734B/en active IP Right Grant
-
2017
- 2017-06-02 HK HK17104907.5A patent/HK1231553A1/zh unknown
-
2021
- 2021-06-28 AU AU2021204419A patent/AU2021204419A1/en not_active Abandoned
- 2021-08-05 US US17/394,521 patent/US11867690B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2015206520B2 (en) | 2021-07-22 |
| CA2972960A1 (fr) | 2015-07-23 |
| AU2015206520A1 (en) | 2016-07-14 |
| IL246734B (en) | 2019-06-30 |
| WO2015109003A1 (fr) | 2015-07-23 |
| JP2017505140A (ja) | 2017-02-16 |
| IL246734A0 (en) | 2016-08-31 |
| JP6606100B2 (ja) | 2019-11-13 |
| EP3094974B1 (fr) | 2019-02-27 |
| EP3094974A1 (fr) | 2016-11-23 |
| HK1231553A1 (zh) | 2017-12-22 |
| ES2728119T3 (es) | 2019-10-22 |
| AU2021204419A1 (en) | 2021-07-22 |
| CA2972960C (fr) | 2022-01-11 |
| DK3094974T3 (da) | 2019-05-27 |
| KR102413041B1 (ko) | 2022-06-23 |
| US20150198584A1 (en) | 2015-07-16 |
| US20210364499A1 (en) | 2021-11-25 |
| US11867690B2 (en) | 2024-01-09 |
| US11137388B2 (en) | 2021-10-05 |
| KR20160110444A (ko) | 2016-09-21 |
| US20160370350A1 (en) | 2016-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL274903A (en) | cell | |
| HK1231553A1 (zh) | 功能性細胞狀態的鑒定 | |
| IL250511A0 (en) | Crystalline forms of ibrutinib | |
| SG11201609265RA (en) | Characterizing states of subject | |
| GB201419865D0 (en) | Solution | |
| GB201407805D0 (en) | Battery condition determination | |
| HUE049608T2 (hu) | Elektrolitoldat | |
| HK1231632A1 (zh) | 電池 | |
| SG11201610831PA (en) | Lithium-sulphur battery | |
| SG11201610430QA (en) | Growth-independent detection of cells | |
| GB2531512B (en) | Context-sensitive identification of regions of interest | |
| GB201411985D0 (en) | Battery | |
| HUE042287T2 (hu) | Lítium-kén cella | |
| GB2531332B (en) | Location identification | |
| GB2559497B (en) | Functional wall-tie | |
| GB201414968D0 (en) | Cell assay | |
| GB201413459D0 (en) | Identification of objects | |
| GB201413650D0 (en) | Wallets | |
| GB201403494D0 (en) | Identifying cell features | |
| GB201410934D0 (en) | T cell | |
| GB201419149D0 (en) | Wallet | |
| GB201417979D0 (en) | Abstract accelerationon | |
| GB201419897D0 (en) | Host cell | |
| GB201418787D0 (en) | Microcarriers | |
| TWM489230U (en) | Improved structure of pin set |